Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial) — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(9 sites)
China
Guangzhou Psychiatric Hospital, Guangzhou, Guangdong the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Second Xiangya Hospital of Central South University, Changsha, Hunan Suzhou Psychiatric Hospital, Suzhou, Jiangsu Shanghai Mental Health Center, Shanghai, Shanghai Municipality Shanghai Xuhui District Mental Health Center, Shanghai, Shanghai Municipality Shanghai Pudong Nanhui Mental Health Center, Shanghai, Shanghai Municipality Shenzhen Kangning Hospital, Shenzhen, Shenzhen Tianjin Anding Hospital, Tianjin, Tianjin Municipality Age range
15 Years – 45 Years
Last updated October 2023